Clovis Oncology Financials
| CLVSDelisted Stock | USD 0.09 0.02 24.00% |
With this module, you can analyze Clovis financials for your investing period. You should be able to track the changes in Clovis Oncology individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Clovis |
Understanding current and past Clovis Oncology Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Clovis Oncology's financial statements are interrelated, with each one affecting the others. For example, an increase in Clovis Oncology's assets may result in an increase in income on the income statement.
The data published in Clovis Oncology's official financial statements usually reflect Clovis Oncology's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Clovis Oncology. For example, before you start analyzing numbers published by Clovis accountants, it's critical to develop an understanding of what Clovis Oncology's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Clovis Oncology's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Clovis Oncology's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Clovis Oncology's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Clovis Oncology. Please utilize our Beneish M Score to check the likelihood of Clovis Oncology's management manipulating its earnings.
Clovis Oncology Stock Summary
Clovis Oncology competes with 51Talk Online, Old Dominion, Vita Coco, Japan Tobacco, and PepsiCo. Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. Clovis Oncology, Inc. was incorporated in 2009 and is headquartered in Boulder, Colorado. Clovis Oncology operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 413 people.| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US1894641000 |
| Business Address | 5500 Flatiron Parkway, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | NYSE Composite |
| Website | www.clovisoncology.com |
| Phone | 303 625 5000 |
| Currency | USD - US Dollar |
You should never invest in Clovis Oncology without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Clovis Stock, because this is throwing your money away. Analyzing the key information contained in Clovis Oncology's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Clovis Oncology Key Financial Ratios
Generally speaking, Clovis Oncology's financial ratios allow both analysts and investors to convert raw data from Clovis Oncology's financial statements into concise, actionable information that can be used to evaluate the performance of Clovis Oncology over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Clovis Oncology reports annually and quarterly.Clovis Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Clovis Oncology's current stock value. Our valuation model uses many indicators to compare Clovis Oncology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Clovis Oncology competition to find correlations between indicators driving Clovis Oncology's intrinsic value. More Info.Clovis Oncology is number one stock in return on asset category among related companies. It is number one stock in profit margin category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Clovis Oncology by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Clovis Oncology's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Clovis Oncology's earnings, one of the primary drivers of an investment's value.Clovis Oncology Market Pulse
| Quote | 0.093 |
| Change(%) | 24.00 |
| Change | 0.02 |
| Open | 0.075 |
| Low | 0.075 |
| High | 0.098 |
| Volume | 0 |
| Exchange | NASDAQ |
About Clovis Oncology Financials
What exactly are Clovis Oncology Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Clovis Oncology's income statement, its balance sheet, and the statement of cash flows. Potential Clovis Oncology investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Clovis Oncology investors may use each financial statement separately, they are all related. The changes in Clovis Oncology's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Clovis Oncology's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze Clovis Oncology Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Clovis Oncology is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Clovis has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Clovis Oncology's financials are consistent with your investment objective using the following steps:- Review Clovis Oncology's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Clovis Oncology's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Clovis Oncology's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Clovis Oncology's stock is overvalued or undervalued.
Clovis Oncology April 19, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Clovis Oncology help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Clovis Oncology. We use our internally-developed statistical techniques to arrive at the intrinsic value of Clovis Oncology based on widely used predictive technical indicators. In general, we focus on analyzing Clovis Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Clovis Oncology's daily price indicators and compare them against related drivers.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 77.55 | |||
| Value At Risk | (15.38) | |||
| Potential Upside | 20.97 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in Clovis Stock
If you are still planning to invest in Clovis Oncology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Clovis Oncology's history and understand the potential risks before investing.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |